All News #Library
Rare Diseases
Avanzanite Bio Secures €32M Series A Investment from MVM Partners
18 Nov 2025 //
BUSINESSWIRE
Avanzanite Partner Agio Receives Positive Opinion for Pyrukynd
17 Oct 2025 //
PHARMIWEB
Avanzanite partners Agios to launch Pyrukynd in Europe
09 Jun 2025 //
BUSINESSWIRE
Avanzanite Bioscience Appoints Sotiris Botozis as GM South Europe
10 Apr 2025 //
BUSINESSWIRE
EC Authorizes Avanzanite Bioscience`s Orphan Drug AKANTIOR
27 Aug 2024 //
BUSINESSWIRE

Market Place
Sourcing Support